The relapse rate after 1 year treatment with oral isotretinoin in Korean patients with mild to moderate acne

Jin Wook Lee, Sei Jin Chang, Dae Hun Suh, Kyung Jeh Sung, Seung Hun Lee, Eung Ho Choi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: The efficacy of isotretinoin in the treatment of acne has been widely established. Recently oral isotretinoin has been used for any grades and any types of acne. There have been many articles on long-term follow up data with oral isotretinoin therapy. Objective: To assess, after 1 year post-treatment with oral isotretinoin, the relapse rate, risk factor which influence the outcome, and the total cumulative dose of oral isotretinoin in mild to moderate acne patients in Korea, prospectively. Material and methods: Patients with mild to moderate acne, visiting out-patient dermatology clinics of four university hospitals have taken oral isotretinoin 0.3-1.0 mg/kg/day over 16 weeks. The outcomes were evaluated by telephone contact, with regard to relapse, further treatment in cases of relapse; subjective assessment of seburn secretion and patient satisfaction. A total of 230 patients were evaluated at the end of the preliminary report, and 124 out of the 230 were contacted in this 1 year follow up. Result: A relapse rate of 25% was obtained on our study. The patient's sex, seborrhea, acne grade prior to treatment, previous severest acne grade did not influence the relapse rate. It appeared that young age and the total cumulative dose (TCD) influenced the percentage of relapse. About 71.3% of patients were satisfied with the result after 1 year post-treatment with oral isotretinoin. Conclusion: The dose schedule, in particular the cumulative dose, was an important factor in determining the relapse rate. It is capable of producing a low relapse rate and long-term remission in mild to moderate acne patients in Korea, if given in a dose regimen of a cumulative dose of 80 mg/kg.

Original languageEnglish
Pages (from-to)675-681
Number of pages7
JournalKorean Journal of Dermatology
Volume42
Issue number6
Publication statusPublished - 2004 Jun 1

Fingerprint

Isotretinoin
Acne Vulgaris
Recurrence
Therapeutics
Korea
Seborrheic Dermatitis
Dermatology
Patient Satisfaction
Telephone
Appointments and Schedules
Outpatients

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Lee, Jin Wook ; Chang, Sei Jin ; Suh, Dae Hun ; Sung, Kyung Jeh ; Lee, Seung Hun ; Choi, Eung Ho. / The relapse rate after 1 year treatment with oral isotretinoin in Korean patients with mild to moderate acne. In: Korean Journal of Dermatology. 2004 ; Vol. 42, No. 6. pp. 675-681.
@article{cb64d039c8e148b49d50c4e6a335571b,
title = "The relapse rate after 1 year treatment with oral isotretinoin in Korean patients with mild to moderate acne",
abstract = "Background: The efficacy of isotretinoin in the treatment of acne has been widely established. Recently oral isotretinoin has been used for any grades and any types of acne. There have been many articles on long-term follow up data with oral isotretinoin therapy. Objective: To assess, after 1 year post-treatment with oral isotretinoin, the relapse rate, risk factor which influence the outcome, and the total cumulative dose of oral isotretinoin in mild to moderate acne patients in Korea, prospectively. Material and methods: Patients with mild to moderate acne, visiting out-patient dermatology clinics of four university hospitals have taken oral isotretinoin 0.3-1.0 mg/kg/day over 16 weeks. The outcomes were evaluated by telephone contact, with regard to relapse, further treatment in cases of relapse; subjective assessment of seburn secretion and patient satisfaction. A total of 230 patients were evaluated at the end of the preliminary report, and 124 out of the 230 were contacted in this 1 year follow up. Result: A relapse rate of 25{\%} was obtained on our study. The patient's sex, seborrhea, acne grade prior to treatment, previous severest acne grade did not influence the relapse rate. It appeared that young age and the total cumulative dose (TCD) influenced the percentage of relapse. About 71.3{\%} of patients were satisfied with the result after 1 year post-treatment with oral isotretinoin. Conclusion: The dose schedule, in particular the cumulative dose, was an important factor in determining the relapse rate. It is capable of producing a low relapse rate and long-term remission in mild to moderate acne patients in Korea, if given in a dose regimen of a cumulative dose of 80 mg/kg.",
author = "Lee, {Jin Wook} and Chang, {Sei Jin} and Suh, {Dae Hun} and Sung, {Kyung Jeh} and Lee, {Seung Hun} and Choi, {Eung Ho}",
year = "2004",
month = "6",
day = "1",
language = "English",
volume = "42",
pages = "675--681",
journal = "Korean Journal of Dermatology",
issn = "0494-4739",
publisher = "Korean Dermatological Association",
number = "6",

}

The relapse rate after 1 year treatment with oral isotretinoin in Korean patients with mild to moderate acne. / Lee, Jin Wook; Chang, Sei Jin; Suh, Dae Hun; Sung, Kyung Jeh; Lee, Seung Hun; Choi, Eung Ho.

In: Korean Journal of Dermatology, Vol. 42, No. 6, 01.06.2004, p. 675-681.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The relapse rate after 1 year treatment with oral isotretinoin in Korean patients with mild to moderate acne

AU - Lee, Jin Wook

AU - Chang, Sei Jin

AU - Suh, Dae Hun

AU - Sung, Kyung Jeh

AU - Lee, Seung Hun

AU - Choi, Eung Ho

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Background: The efficacy of isotretinoin in the treatment of acne has been widely established. Recently oral isotretinoin has been used for any grades and any types of acne. There have been many articles on long-term follow up data with oral isotretinoin therapy. Objective: To assess, after 1 year post-treatment with oral isotretinoin, the relapse rate, risk factor which influence the outcome, and the total cumulative dose of oral isotretinoin in mild to moderate acne patients in Korea, prospectively. Material and methods: Patients with mild to moderate acne, visiting out-patient dermatology clinics of four university hospitals have taken oral isotretinoin 0.3-1.0 mg/kg/day over 16 weeks. The outcomes were evaluated by telephone contact, with regard to relapse, further treatment in cases of relapse; subjective assessment of seburn secretion and patient satisfaction. A total of 230 patients were evaluated at the end of the preliminary report, and 124 out of the 230 were contacted in this 1 year follow up. Result: A relapse rate of 25% was obtained on our study. The patient's sex, seborrhea, acne grade prior to treatment, previous severest acne grade did not influence the relapse rate. It appeared that young age and the total cumulative dose (TCD) influenced the percentage of relapse. About 71.3% of patients were satisfied with the result after 1 year post-treatment with oral isotretinoin. Conclusion: The dose schedule, in particular the cumulative dose, was an important factor in determining the relapse rate. It is capable of producing a low relapse rate and long-term remission in mild to moderate acne patients in Korea, if given in a dose regimen of a cumulative dose of 80 mg/kg.

AB - Background: The efficacy of isotretinoin in the treatment of acne has been widely established. Recently oral isotretinoin has been used for any grades and any types of acne. There have been many articles on long-term follow up data with oral isotretinoin therapy. Objective: To assess, after 1 year post-treatment with oral isotretinoin, the relapse rate, risk factor which influence the outcome, and the total cumulative dose of oral isotretinoin in mild to moderate acne patients in Korea, prospectively. Material and methods: Patients with mild to moderate acne, visiting out-patient dermatology clinics of four university hospitals have taken oral isotretinoin 0.3-1.0 mg/kg/day over 16 weeks. The outcomes were evaluated by telephone contact, with regard to relapse, further treatment in cases of relapse; subjective assessment of seburn secretion and patient satisfaction. A total of 230 patients were evaluated at the end of the preliminary report, and 124 out of the 230 were contacted in this 1 year follow up. Result: A relapse rate of 25% was obtained on our study. The patient's sex, seborrhea, acne grade prior to treatment, previous severest acne grade did not influence the relapse rate. It appeared that young age and the total cumulative dose (TCD) influenced the percentage of relapse. About 71.3% of patients were satisfied with the result after 1 year post-treatment with oral isotretinoin. Conclusion: The dose schedule, in particular the cumulative dose, was an important factor in determining the relapse rate. It is capable of producing a low relapse rate and long-term remission in mild to moderate acne patients in Korea, if given in a dose regimen of a cumulative dose of 80 mg/kg.

UR - http://www.scopus.com/inward/record.url?scp=4143125471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143125471&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:4143125471

VL - 42

SP - 675

EP - 681

JO - Korean Journal of Dermatology

JF - Korean Journal of Dermatology

SN - 0494-4739

IS - 6

ER -